PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Kemin Industries, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kemin Reveals Dioxin Testing Program - Kemin Industries reveals an advanced program for detecting both dioxins and PCBs (toxic dioxin congeners) in raw ingredients
Kemin Reveals Dioxin Testing Program

 

NewswireToday - /newswire/ - Des Moines, IA, United States, 2011/01/13 - Kemin Industries reveals an advanced program for detecting both dioxins and PCBs (toxic dioxin congeners) in raw ingredients.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr. John Springate, president of Kemin AgriFoods, noted that the program was initiated in 2010 to test raw ingredients used by the company that came from natural sources. He stated, "Kemin purchases and farms a number of botanical materials, oils and animal products that could potentially be contaminated with these compounds. As part of our rigorous quality control programs, we have installed state-of-the-art analytical equipment and laboratory procedures to test these materials for dioxins and PCBs.”

The company’s dioxin testing program includes the use of a high-resolution gas chromatography-magnetic sector mass spectrometer that iscapable of detecting dioxin and PCB isomers at levels exceeding EU standards. This testing program is in place at all of Kemin’s manufacturing sites in Asia, China, Europe, India, South America and the United States.

In addition to the dioxin testing program, Kemin follows Hazard Analysis and Critical Control Points (HACCP) and Feed Additives and Premixtures Quality System (FAMI-QS) programs. The Kemin facility in North America was also the first to receive the FAMI-QS/International Safe Feed/Safe Food (I-SF/SF) certificate last September.

About Kemin® – Inspired Molecular Solutions™
Founded in 1961, Kemin Industries (kemin.com) is celebrating its 50th Anniversary of providing “inspired molecular solutions” specifically developed to provide nutrition and health benefits for humans and animals. Kemin distributes approximately 500 specialty ingredients worldwide to the feed and food industries as well as to the health, nutrition and beauty markets. Kemin ingredients positively impact more than 1.3 billion people a day.

A global, privately-held corporation headquartered in Des Moines, Iowa (USA), Kemin has experienced double-digit growth in the last several years. The company has more than 1,200 employees and operates in 60 countries with manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United States.

About Kemin AgriFoods
Kemin AgriFoods responds to the needs of today’s world population to be safe, to be efficient and to be healthy. Kemin AgriFoods brings value to the feed industry by working in partnership with their customers. TOTAL NUTRITION™ offers a wide variety of solutions with a judicious range of nutricines and nutrients to produce safe feed, in an efficient way that provides optimal livestock health.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kemin Reveals Dioxin Testing Program

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Erin Hockman - Kemin.com 
515-559-5349 erin.hockman[.]kemin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)